{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:57:18Z","timestamp":1788361038979,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.isci.2024.110405","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T23:57:46Z","timestamp":1719619066000},"page":"110405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant"],"prefix":"10.1016","volume":"27","author":[{"given":"Junhao","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0775-6623","authenticated-orcid":false,"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.110405_bib1","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2024.110405_bib3","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/S1473-3099(23)00573-X","article-title":"Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86","volume":"23","author":"Yang","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.110405_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-023-06750-w","article-title":"Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike","volume":"624","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.110405_bib5","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/S1473-3099(23)00575-3","article-title":"Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant","volume":"23","author":"Uriu","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.110405_bib6","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1016\/S1473-3099(23)00588-1","article-title":"Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses","volume":"23","author":"Sheward","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.110405_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112443","article-title":"Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants","volume":"42","author":"Qu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.110405_bib8","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1016\/j.vaccine.2023.10.051","article-title":"Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86","volume":"41","author":"Lasrado","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.110405_bib9","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/s41467-023-43703-3","article-title":"Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant","volume":"14","author":"Khan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110405_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02473-21","article-title":"A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants","volume":"12","author":"Haslwanter","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.110405_bib11","article-title":"Covid-19: WHO adds JN.1 as new variant of interest","volume":"383","author":"Mun-Keat","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2024.110405_bib12","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.110405_bib13","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","article-title":"Virological characteristics of the SARS-CoV-2 JN.1 variant","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.110405_bib14","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJMc2302462","article-title":"Durability of Bivalent Boosters against Omicron Subvariants","volume":"388","author":"Lin","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.110405_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.110405_bib17","first-page":"315","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants","volume":"32","author":"Qian","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.110405_bib18","first-page":"e80","article-title":"Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster","volume":"24","author":"Ulrika","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.isci.2024.110405_bib19","article-title":"Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine","author":"Kayvon","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2024.110405_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00044-21","article-title":"Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays","volume":"95","author":"Yu","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2024.110405_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65962","article-title":"SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation","volume":"10","author":"Sanders","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.isci.2024.110405_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.775224","article-title":"The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern","volume":"9","author":"Lin","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.isci.2024.110405_bib23","article-title":"Immune Imprinting and Implications for COVID-19","volume":"11","author":"Zhou","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2024.110405_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1269194","article-title":"Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak","volume":"11","author":"Ye","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.isci.2024.110405_bib25","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e6","article-title":"Adenovirus Vectors: Excellent Tools for Vaccine Development","volume":"21","author":"Chang","year":"2021","journal-title":"Immune Netw."},{"key":"10.1016\/j.isci.2024.110405_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2024.110405_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2286260","article-title":"Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies","volume":"13","author":"Huo","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.isci.2024.110405_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chom.2023.11.010","article-title":"Pre-existing SARS-2-specific T\u00a0cells are predicted to cross-recognize BA.2.86","volume":"32","author":"Sette","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.110405_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chom.2023.12.010","article-title":"Memory T\u00a0cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant","volume":"32","author":"Muller","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.110405_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110405_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110405_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.celrep.2015.08.055","article-title":"IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein","volume":"13","author":"Yu","year":"2015","journal-title":"Cell Rep."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224016304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224016304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:19:53Z","timestamp":1731428393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224016304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2589004224016304"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.110405","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.110405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110405"}}